Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Health Sci (Qassim). 2013 Jan;7(1):77-89.

Cucurbitacins - a promising target for cancer therapy.

Author information

1
College of Medicine, Qassim University, Kingdom of Saudi Arabia.

Abstract

During the last decades a large number of cucurbitacins have been isolated from various plant species belonging to other plant families than Cucurbitaceae. Although the roots and the fruits of plant belong to these Cucurbitaceae species are very bitter, they have been used as folk medicines in some countries because of their wide spectrum of pharmacological activities such as anti-inflammation and anticancer effects. In the last ten years, cucurbitacins had been shown to inhibit proliferation and induced apoptosis utilizing a long array of in vitro and in vivo cancer cell models. Several molecular targets for cucurbitacins have been discovered, such as fibrous-actin, signal transducer and activator of transcription (STAT), cyclooxygenase-2, etc. This review aimed at elucidating the natural sources of some cucurbitacin compounds, their chemical structure and derivatives, physical properties, biological activities and mechanism by which they reduce the proliferation human cancer cells. This widens our armaments against a devastating disease that we are failing to face.

KEYWORDS:

Cucurbitacin; Janus kinase (JAK); STAT; anti-inflammation; anti-tumor; apoptosis

PMID:
23559908
PMCID:
PMC3612419
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center